Industry Insider Activity

Drug Manufacturers - General insider activity

Concentrated executive and director transaction evidence across 11 companies, with acquisition/disposal balance, filing cadence, value concentration, and linked company research.

Latest filing 20 Jul 2026 505 filings tracked

Top-level read

Net insider buying

Drug Manufacturers - General shows 302 acquisition filings against 203 disposal filings. The largest stored filing is $26.1M in AMGN by BRADWAY, ROBERT A.

Net value $48.2Macquisitions minus disposals
Companies 11with stored filings
Total filings 505stored transaction rows
Acquisition value $105.6M302 acquisitions
Disposal value $57.4M203 disposals
Largest filing $26.1Mreported transaction value

Filing cadence

Last 12 active months
Mar 2026 118
Apr 2026 118
May 2026 162
Jun 2026 80
Jul 2026 27

Acquisitions 59.8% · Disposals 40.2%

Company Reads

Most active company insider tapes

11 shown

Transaction Evidence

Latest filings in Drug Manufacturers - General

Showing 181-210 of 505
Date 6 May 2026
Symbol AMGNAmgen Inc
Insider BUSCH, MATTHEW C.VP, Finance & CAO
Side Disposal
Shares 50
Value 16480
Industry Drug Manufacturers - General
Date 6 May 2026
Symbol OGNOrganon & Co
Insider HOLZBAUR, LYNETTESVP and Corporate Controller
Side Acquisition
Shares 46
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider BRADWAY, ROBERT ADirector, Chairman, CEO and President
Side Acquisition
Shares 79176
Value 26095618
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider GORDON, MURDOEVP, Global Commercial Ops
Side Acquisition
Shares 23752
Value 7828422
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider GRIFFITH, PETER H.EVP & CFO
Side Acquisition
Shares 23752
Value 7828422
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider BRADNER, JAMES E.EVP, Research and Development
Side Acquisition
Shares 21773
Value 7176163
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider REESE, DAVID MEVP & Chief Technology Officer
Side Acquisition
Shares 19002
Value 6262869
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider SANTOS, ESTEBANEVP, Operations
Side Acquisition
Shares 17814
Value 5871316
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider GRAHAM, JONATHAN PEVP & Gen. Counsel & Sec.
Side Acquisition
Shares 17022
Value 5610281
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider MILLER, DEREKSVP, Human Resources
Side Acquisition
Shares 5938
Value 1957105
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider KHOSLA, RACHNASVP, Business Development
Side Acquisition
Shares 3266
Value 1076441
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider GRYGIEL, NANCY A.SVP & CCO
Side Acquisition
Shares 3167
Value 1043812
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider BUSCH, MATTHEW C.VP, Finance & CAO
Side Acquisition
Shares 2969
Value 978553
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider BRADNER, JAMES E.EVP, Research and Development
Side Acquisition
Shares 3337
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider BRADWAY, ROBERT ADirector, Chairman, CEO and President
Side Acquisition
Shares 12136
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider BUSCH, MATTHEW C.VP, Finance & CAO
Side Acquisition
Shares 455
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider DRAKE, MICHAEL VDirector
Side Acquisition
Shares 80
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider GORDON, MURDOEVP, Global Commercial Ops
Side Acquisition
Shares 3640
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider GRAHAM, JONATHAN PEVP & Gen. Counsel & Sec.
Side Acquisition
Shares 2609
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider GRIFFITH, PETER H.EVP & CFO
Side Acquisition
Shares 3640
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider GRYGIEL, NANCY A.SVP & CCO
Side Acquisition
Shares 485
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider HOLLEY, CHARLES MDirector
Side Acquisition
Shares 129
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider ISHRAK, OMARDirector
Side Acquisition
Shares 106
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider KHOSLA, RACHNASVP, Business Development
Side Acquisition
Shares 500
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider MILLER, DEREKSVP, Human Resources
Side Acquisition
Shares 910
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider REESE, DAVID MEVP & Chief Technology Officer
Side Acquisition
Shares 2912
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol AMGNAmgen Inc
Insider SANTOS, ESTEBANEVP, Operations
Side Acquisition
Shares 2730
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol MRKMerck & Company Inc
Insider DAVIS, ROBERT MDirector, Chairman, CEO & President
Side Acquisition
Shares 139697
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol MRKMerck & Company Inc
Insider DAVIS, ROBERT MDirector, Chairman, CEO & President
Side Acquisition
Shares 47724
Value 0
Industry Drug Manufacturers - General
Date 5 May 2026
Symbol MRKMerck & Company Inc
Insider DELUCA, RICHARD R.EVP&Pres, Merck Animal Heallth
Side Acquisition
Shares 11931
Value 0
Industry Drug Manufacturers - General